Picture of Astria Therapeutics logo

ATXS — Astria Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Astria Therapeutics Q2 EPS USD -0.45

Aug 7 (Reuters) - Astria Therapeutics Q2 operating expenses USD 15.102
million.
* Q2 net income USD -12.566 million
* Q2 EPS USD -0.45
* Q2 income from operations USD -15.102 million

Recent news on Astria Therapeutics

See all news